TIMP-1, for example, has been shown to promote oligodendrocyte differentiation and enhance CNS myelination, suggesting that MSC-NP-derived TIMP-1 may play a therapeutic role in the context of MS [23,24]. Here, TIMP1 is linked to myeloid sarcoma.